DMRA compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

DMRADamora Therapeutics, Inc.

Mkt capRevenueRevenue

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

Compare

DMRADamora Therapeutics, Inc.

JBIOJade Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DMRA 3

—Paragonunlistedsupplier

—Pre-Acquisition Damoraunlistedsupplier

—Bridge Medicinesunlistedsupplier

Shared 0

No shared counterparties.

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

DMRADamora Therapeutics, Inc.

21.50▼−2.30%· post 21.50

Mkt cap$1.3B

JBIOJade Biosciences, Inc.

14.07▼−1.19%· post 14.07

ClosedOct 30 '26

Mkt cap$894.2M

Compare

ClosedOct 30 '26

DMRADamora Therapeutics, Inc.

JBIOJade Biosciences, Inc.

21.50▼−2.30%post 21.50

Price

14.07▼−1.19%post 14.07

$1.3B

Mkt cap

$894.2M

DMRA21.50▼−2.30%vsJBIO14.07▼−1.19%ClosedOct 30 '26